Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Eisai, Foresee, Hutchmed, Iaso, Innovent Biologics, J Ints Bio, Mezzion, Revive, Takeda, United.